VeriMomSollte ich dipropylene glycol salicylate in der Schwangerschaft meiden? | VeriMom
No evidence of a harmonised CLP H360 or an EU Annex II/III restriction for dipropylene glycol salicylate was found (no EU ban/restriction). Several safety sources treat it as an ester of salicylic acid; the CIR assessment of salicylic acid/salicylates and government reviews report reproductive/developmental effects only at relatively high systemic doses in animals, not from topical cosmetic use. Some SDSs list H361 but these appear to be company self-classifications rather than a harmonised ECHA classification. Given the structural link to salicylic acid (structural/class-based concern) but absence of harmonised classification or robust reproductive studies on this exact compound, I assign a conservative h=1 (structural/class concern), m=1 (theoretical/mechanistic plausibility via ester → salicylate), e=1 (low but measurable dermal exposure for typical cosmetic use). Sources: PubChem, CIR salicylates review, Canada draft screening (salicylates), EWG, manufacturer/SDS notes.
ECHA regulatory hazard statements
- •H361
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- Ist dipropylene glycol salicylate in der Schwangerschaft sicher?
- No evidence of a harmonised CLP H360 or an EU Annex II/III restriction for dipropylene glycol salicylate was found (no EU ban/restriction). Several safety sources treat it as an ester of salicylic acid; the CIR assessment of salicylic acid/salicylates and government reviews report reproductive/developmental effects only at relatively high systemic doses in animals, not from topical cosmetic use. Some SDSs list H361 but these appear to be company self-classifications rather than a harmonised ECHA classification. Given the structural link to salicylic acid (structural/class-based concern) but absence of harmonised classification or robust reproductive studies on this exact compound, I assign a conservative h=1 (structural/class concern), m=1 (theoretical/mechanistic plausibility via ester → salicylate), e=1 (low but measurable dermal exposure for typical cosmetic use). Sources: PubChem, CIR salicylates review, Canada draft screening (salicylates), EWG, manufacturer/SDS notes.
- Ist dipropylene glycol salicylate während des Stillens sicher?
- Same rationale as pregnancy: no direct harmonised reproductive classification or authoritative restriction for this specific ester, but it is an ester of salicylic acid which can be systemically active after absorption/hydrolysis. Dermal cosmetic use is expected to give low but measurable maternal systemic exposure in normal use; transfer into breastmilk would be contingent on maternal systemic levels. Conservative approach: same scores as pregnancy.
- Ist dipropylene glycol salicylate sicher für Babyhaut?
- Hazard (h) and mechanism (m) unchanged — no infant-specific reproductive/developmental data; however exposure (e) increased by +1 because infant skin (0–3 y) has higher surface-area-to-body-weight and an immature barrier, so measured dermal absorption for the parent compound would translate to higher internal exposure in infants. There is no evidence that infant topical use has produced harm for this specific ingredient, but prudence supports increased exposure score for baby skin.
- Wie bewertet VeriMom dipropylene glycol salicylate?
- VeriMom bewertet dipropylene glycol salicylate mit 27/100 (hohes Risiko) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu dipropylene glycol salicylate?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu dipropylene glycol salicylate basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.